NCT03338712

Brief Summary

Recurrence free survival The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association. Data will be updated once yearly for until death.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Feb 2010

Longer than P75 for all trials

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

November 2, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 9, 2017

Completed
Last Updated

December 12, 2023

Status Verified

November 1, 2017

Enrollment Period

6.2 years

First QC Date

November 2, 2017

Last Update Submit

December 5, 2023

Conditions

Prostate CancerRadical Prostatectomy

Outcome Measures

Primary Outcomes (1)

  • Recurrence free survival

    The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association.

    Up to 120 months. From date of inclusion until date of death from any cause

Secondary Outcomes (1)

  • Cancer specific survival

    Up to 120 months. From date of inclusion until date of death from any cause

Eligibility Criteria

Age35 Years - 80 Years
Sexmale
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

* Male * Patients with clinically localised high risk prostate cancer

You may qualify if:

  • Years to 80 Years
  • Male
  • Patients with clinically localised high risk prostate cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Prostatic Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 2, 2017

First Posted

November 9, 2017

Study Start

February 1, 2010

Primary Completion

April 1, 2016

Study Completion

April 1, 2016

Last Updated

December 12, 2023

Record last verified: 2017-11

Data Sharing

IPD Sharing
Will not share